Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Earnings presentation on Audited Financial Results (Standalone & Consolidated) for Q4 and FY ended March 31, 202410-05-2024
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor Presentation
Earnings presentation on Audited Financial Results (Standalone & Consolidated) for Q4 and FY ended March 31, 2024Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith Press Release on Audited Financial Results (Standalone & Consolidated) for Q4 and FY ended March 31, 2024Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of ESOP